Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

How is LSDs prevalence & epidemiology different in our region?

Global use of RAM and Thromboprophylaxis in hospitalized patients

Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.

Benefit of Prophylaxis for High-Risk Surgical Patients

Pompe

Slowing of brain atrophy with Teriflunomide

Atherosclerotic Cardiovascular Disease Risk Assessment

Why Sanofi Pasteur?

Sanofi Pasteur at Glance

Maternity Clot Risk Model to Predict Women at Risk of VTE

How do you know if you or a loved one has ASMD?

What is the role of Artificial Intelligence in accelerating patient's diagnosis?